Brief Developmental Exposure to Fluoxetine Causes Life-Long Alteration of the Brain Transcriptome in Zebrafish

Fluoxetine (FLX) and other selective serotonin reuptake inhibitors are widely used to treat depressive disorders during pregnancy. Early-life exposure to FLX is known to disrupt the normal function of the stress axis in humans, rodents, and teleosts. We used a zebrafish line with a cortisol-inducibl...

Full description

Bibliographic Details
Main Authors: Amin Nozari, Remi Gagné, Chunyu Lu, Carole Yauk, Vance L. Trudeau
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.847322/full
_version_ 1828367815165345792
author Amin Nozari
Remi Gagné
Chunyu Lu
Carole Yauk
Carole Yauk
Vance L. Trudeau
author_facet Amin Nozari
Remi Gagné
Chunyu Lu
Carole Yauk
Carole Yauk
Vance L. Trudeau
author_sort Amin Nozari
collection DOAJ
description Fluoxetine (FLX) and other selective serotonin reuptake inhibitors are widely used to treat depressive disorders during pregnancy. Early-life exposure to FLX is known to disrupt the normal function of the stress axis in humans, rodents, and teleosts. We used a zebrafish line with a cortisol-inducible fluorescent transgene to study the effects of developmental daily exposure to FLX (54 µg/L) on the transcriptomic profile of brain tissues in exposed larvae and later as 6-month-old adults. High throughput RNA sequencing was conducted on brain tissues in unstressed and stressed conditions. Long-lasting effects of FLX were observed in telencephalon (Tel) and hypothalamus (Hyp) of adult zebrafish with 1927 and 5055 genes significantly (≥1.2 fold-change, false-discovery p-value < 0.05) dysregulated in unstressed condition, respectively. Similar findings were observed in Hyp with 1245 and 723 genes being significantly dysregulated in stressed adults, respectively. Differentially expressed genes converted to Homo sapiens orthologues were used for Ingenuity Pathway Analysis. The results showed alteration of pathways involved in neuroendocrine signaling, cholesterol metabolism and synaptogenesis. Enriched networks included lipid metabolism, molecular transport, and nervous system development. Analysis of putative upstream transcription regulators showed potential dysregulation of clocka and nr3c1 which control circadian rhythm, stress response, cholesterol metabolism and histone modifications. Several genes involved in epigenetic regulation were also affected by FLX, including dnmt3a, adarb1, adarb2, hdac4, hdac5, hdac8, and atf2. We report life-long disruptive effects of FLX on pathways associated with neuroendocrine signaling, stress response and the circadian rhythm, and all of which are implicated in the development of depressive disorders in humans. Our results raise concern for the persistent endocrine-disrupting potential of brief antidepressant exposure during embryonic development.
first_indexed 2024-04-14T06:03:12Z
format Article
id doaj.art-f0c88398b829485bb2e7898a9ec07954
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-14T06:03:12Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-f0c88398b829485bb2e7898a9ec079542022-12-22T02:08:41ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-04-011310.3389/fendo.2022.847322847322Brief Developmental Exposure to Fluoxetine Causes Life-Long Alteration of the Brain Transcriptome in ZebrafishAmin Nozari0Remi Gagné1Chunyu Lu2Carole Yauk3Carole Yauk4Vance L. Trudeau5Department of Biology, University of Ottawa, Ottawa, ON, CanadaEnvironmental Health Science and Research Bureau, Health Canada, Ottawa, ON, CanadaDepartment of Biology, University of Ottawa, Ottawa, ON, CanadaDepartment of Biology, University of Ottawa, Ottawa, ON, CanadaEnvironmental Health Science and Research Bureau, Health Canada, Ottawa, ON, CanadaDepartment of Biology, University of Ottawa, Ottawa, ON, CanadaFluoxetine (FLX) and other selective serotonin reuptake inhibitors are widely used to treat depressive disorders during pregnancy. Early-life exposure to FLX is known to disrupt the normal function of the stress axis in humans, rodents, and teleosts. We used a zebrafish line with a cortisol-inducible fluorescent transgene to study the effects of developmental daily exposure to FLX (54 µg/L) on the transcriptomic profile of brain tissues in exposed larvae and later as 6-month-old adults. High throughput RNA sequencing was conducted on brain tissues in unstressed and stressed conditions. Long-lasting effects of FLX were observed in telencephalon (Tel) and hypothalamus (Hyp) of adult zebrafish with 1927 and 5055 genes significantly (≥1.2 fold-change, false-discovery p-value < 0.05) dysregulated in unstressed condition, respectively. Similar findings were observed in Hyp with 1245 and 723 genes being significantly dysregulated in stressed adults, respectively. Differentially expressed genes converted to Homo sapiens orthologues were used for Ingenuity Pathway Analysis. The results showed alteration of pathways involved in neuroendocrine signaling, cholesterol metabolism and synaptogenesis. Enriched networks included lipid metabolism, molecular transport, and nervous system development. Analysis of putative upstream transcription regulators showed potential dysregulation of clocka and nr3c1 which control circadian rhythm, stress response, cholesterol metabolism and histone modifications. Several genes involved in epigenetic regulation were also affected by FLX, including dnmt3a, adarb1, adarb2, hdac4, hdac5, hdac8, and atf2. We report life-long disruptive effects of FLX on pathways associated with neuroendocrine signaling, stress response and the circadian rhythm, and all of which are implicated in the development of depressive disorders in humans. Our results raise concern for the persistent endocrine-disrupting potential of brief antidepressant exposure during embryonic development.https://www.frontiersin.org/articles/10.3389/fendo.2022.847322/fullembryonic developmentbrain transcriptomefluoxetinelife-long effectRNA sequencingzebrafish
spellingShingle Amin Nozari
Remi Gagné
Chunyu Lu
Carole Yauk
Carole Yauk
Vance L. Trudeau
Brief Developmental Exposure to Fluoxetine Causes Life-Long Alteration of the Brain Transcriptome in Zebrafish
Frontiers in Endocrinology
embryonic development
brain transcriptome
fluoxetine
life-long effect
RNA sequencing
zebrafish
title Brief Developmental Exposure to Fluoxetine Causes Life-Long Alteration of the Brain Transcriptome in Zebrafish
title_full Brief Developmental Exposure to Fluoxetine Causes Life-Long Alteration of the Brain Transcriptome in Zebrafish
title_fullStr Brief Developmental Exposure to Fluoxetine Causes Life-Long Alteration of the Brain Transcriptome in Zebrafish
title_full_unstemmed Brief Developmental Exposure to Fluoxetine Causes Life-Long Alteration of the Brain Transcriptome in Zebrafish
title_short Brief Developmental Exposure to Fluoxetine Causes Life-Long Alteration of the Brain Transcriptome in Zebrafish
title_sort brief developmental exposure to fluoxetine causes life long alteration of the brain transcriptome in zebrafish
topic embryonic development
brain transcriptome
fluoxetine
life-long effect
RNA sequencing
zebrafish
url https://www.frontiersin.org/articles/10.3389/fendo.2022.847322/full
work_keys_str_mv AT aminnozari briefdevelopmentalexposuretofluoxetinecauseslifelongalterationofthebraintranscriptomeinzebrafish
AT remigagne briefdevelopmentalexposuretofluoxetinecauseslifelongalterationofthebraintranscriptomeinzebrafish
AT chunyulu briefdevelopmentalexposuretofluoxetinecauseslifelongalterationofthebraintranscriptomeinzebrafish
AT caroleyauk briefdevelopmentalexposuretofluoxetinecauseslifelongalterationofthebraintranscriptomeinzebrafish
AT caroleyauk briefdevelopmentalexposuretofluoxetinecauseslifelongalterationofthebraintranscriptomeinzebrafish
AT vanceltrudeau briefdevelopmentalexposuretofluoxetinecauseslifelongalterationofthebraintranscriptomeinzebrafish